GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

Date:




The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Vancouver’s SPELL Set To Release Cinematic New LP Wretched Heart, New Single Now Streaming

Vancouver-based metal outfit Spell are poised to deliver their...

Lysol Maker Reckitt Halts Production in Bahrain Amid Middle East Conflict

The Lysol maker halted production at a plant in...

California school hired a coach, but police say he moonlighted as a pimp

Shwetha SurendranMar 5, 2026, 07:00 AM ETCloseShwetha Surendran is...